Neuropathologic Evidence that the Lewy Body Variant of Alzheimer Disease Represents Coexistence of Alzheimer Disease and Idiopathic Parkinson Disease

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  1995-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00005072-199801000-00006PMID 9600196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”

  2004cited by this paper
• A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease

  2004cited by this paper
• Diffuse Lewy body disease

  2004cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease

  1996cited by this paper
• Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease.

  1995cited by this paper
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies

  1995cited by this paper
• Neocortical changes in Parkinson's disease, revisited.

  1994cited by this paper
• Alzheimer's disease and Lewy body disease: A comparative clinicopathological study

  1994cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• Pathology and Biology of the Lewy Body

  1993cited by this paper
• Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa

  1993cited by this paper
• A clinicopathologic study of 100 cases of Parkinson's disease.

  1993cited by this paper
• An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease

  1992cited by this paper
• Operational criteria for senile dementia of Lewy body type (SDLT)

  1992cited by this paper
• Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease

  1991cited by this paper
• Interrater reliability of extrapyramidal signs in a group assessed for dementia.

  1991cited by this paper
• Diffuse lewy body disease in Japan

  1990cited by this paper
• The Lewy body variant of Alzheimer's disease

  1990cited by this paper
• Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients

  1987cited by this paper
• Lewy Body Dementia Without Alzheimer Changes

  1986cited by this paper
• Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

  1984cited by this paper
• The Morphological Basis of Dementia in Parkinson’s Disease

  1984cited by this paper
• Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system

  1976cited by this paper
• CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM

  1969cited by this paper
• Cytoplasmic inclusions in ganglion cells associated with parkinsonian states: a neurocellular change studied in 53 cases and 206 controls.

  1959cited by this paper

• Potential common pathogenesis of several neurodegenerative diseases

  2025cites this paper
• Genetic associations with dementia‐related proteinopathy: Application of item response theory

  2024cites this paper
• Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer’s Disease

  2021cites this paper
• Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

  2019cites this paper
• In Vivo Positron Emission Tomography of Extrastriatal Non-Dopaminergic Pathology in Parkinson Disease

  2018cites this paper
• Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease

  2018cites this paper
• Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

  2018cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• Neuropathologic Changes of Multiple System Atrophy and Diffuse Lewy Body Disease

  2014cites this paper
• The role of chaperone proteins in neurodegenerative diseases

  2013cites this paper
• Management of psychosis and dementia

  2013cites this paper
• Demenz mit Lewy-Körpern

  2013cites this paper
• Neuropsychologic assessment in collaborative Parkinson's disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington

  2013cites this paper
• Involvement of the Spinal Cord in Parkinson's Disease

  2012cites this paper
• Neuropathology of Dementia in Parkinson's Disease

  2011cites this paper
• Attention and novelty processing in stroke and Parkinson's disease

  2011cites this paper
• Parkinson's Disease Dementia and Potential Therapeutic Strategies

  2011cites this paper
• Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases

  2010cites this paper
• Conceptual Evolution in Alzheimer's Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative Disease

  2010cites this paper
• Age and apoE associations with complex pathologic features in Alzheimer's disease.

  2008influential citation
• Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.

  2008cites this paper
• Immunohistochemistry Applications in Pathology

  2008cites this paper
• Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms

  2008cites this paper
• Relevance of COX‐2 gene expression in dementia with lewy bodies associated with Alzheimer pathology

  2008cites this paper
• Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies

  2008influential citation
• Parkinson Disease: Phenomenology and Treatment of the Most Common Psychiatric Symptoms

  2008cites this paper
• Lewy Body Disorders

  2007cites this paper
• Management of the behavioral aspects of Parkinson’s disease

  2007cites this paper
• Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study.

  2007cites this paper
• Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

  2006cites this paper
• Diseases: New Concepts of Pathogenesis and Their Therapeutic Implications

  2006cites this paper
• Characteristics of alpha-synucleinopathy in centenarians

  2006cites this paper
• Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease

  2006cites this paper
• Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

  2006cites this paper
• A Possible Cellular Mechanism of Neuronal Loss in the Dorsal Root Ganglia of Dystonia musculorum (dt) Mice

  2006cites this paper
• Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?

  2006cites this paper
• Alzheimer ’ s disease and frontotemporal dementia : prospects of a tailored therapy ?

  2006cites this paper
• A View on Early Diagnosis of Dementias from Neuropathology

  2006cites this paper
• Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

  2006cites this paper
• Confronting complexity : a comprehensive statistical and computational strategy for identifying the missing link between genotype and phenotype.

  2006cites this paper
• Dementia with Lewy bodies.

  2006cites this paper
• N-isopropyl-p- 123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.

  2005cites this paper
• Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.

  2005cites this paper
• Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

  2005cites this paper
• Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)

  2005cites this paper
• Title Alpha-synuclein lesions in normal aging , Parkinson disease , and Alzheimer disease : Evidence from the Baltimore Longitudinal Study of Aging ( BLSA ) Permalink

  2005cites this paper
• Lewy body-related α-synucleinopathy in the aged human brain

  2004cites this paper
• Lewy body-related alpha-synucleinopathy in the aged human brain.

  2004cites this paper
• Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease

  2004cites this paper
• [Lewy bodies, a misleading marker for Parkinson's disease?].

  2003cites this paper
• Can Alzheimer’s Disease and Dementias with Lewy Bodies be Distinguished Clinically?

  2003cites this paper
• α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

  2003cites this paper
• Neuropathological Distinctions and Similarities in Movement Disorders with Dementia

  2003cites this paper
• α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

  2003cites this paper
• Le corps de Lewy, marqueur abusif de la maladie de Parkinson ?

  2003cites this paper
• Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.

  2002cites this paper
• Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

  2002cites this paper
• Disturbance of the nigro-amygdaloid connections in dementia with Lewy bodies.

  2002cites this paper
• Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

  2002cites this paper
• Cortical Lewy body pathology in the diagnosis of dementia

  2001cites this paper
• Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease

  2001cites this paper
• [An autopsy case of dementia with Lewy bodies who showed the typical parkinsonism in the initial five years].

  2000cites this paper
• Inflammation in neurodegenerative disease: good, bad, or irrelevant?

  2000cites this paper
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

  2000cites this paper
• Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease

  2000cites this paper
• APOE and the risk of PD with or without dementia in a population-based study

  2000cites this paper
• A review of the cognitive and behavioral symptoms in dementia with Lewy bodies.

  2000cites this paper
• [Dementia with Lewy bodies].

  2000cites this paper
• Activated microglial cells and complement factors are unrelated to cortical Lewy bodies

  2000cites this paper
• Advances in Dementia Research

  2000cites this paper
• Dementia with Lewy bodies: prevalence, clinical spectrum and natural history.

  2000cites this paper
• Golf ball epilepsy

  2000cites this paper
• Demenz mit Lewy-Körperchen

  2000influential citation
• Morphological substrates of mental dysfunction in Lewy body disease: an update.

  2000cites this paper
• Lewy body dementia.

  1999cites this paper
• Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia

  1999cites this paper
• What is new in degenerative dementia disorders?

  1999cites this paper
• Alzheimer’s disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration

  1999cites this paper
• Neocortical Synapse Density and Braak Stage in the Lewy Body Variant of Alzheimer Disease: A Comparison with Classic Alzheimer Disease and Normal Aging

  1998cites this paper
• Commentary on "Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson's disease (1998;57:39-46)".

  1998cites this paper
• Neuropathology of Alzheimer's Disease and the Lewy Body Variant of Alzheimer's Disease: Synapse Density and Pathological Staging: New Pieces of the Puzzle

  1997cites this paper
• Structural basis of dementia in neurodegenerative disorders

  1996cites this paper